Non-FDA-approved GLP-1 receptor agonists remain largely available despite recent resolutions to drug shortages, data at the ...

Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are ...

A 2026 informational overview of Earth Echo Foods' ceremonial-grade cacao formulation, GLP-1 research context referenced in chocolate-based weight management discussions, ingredient disclosures, blue ...

With weight loss drugs on the rise, restaurants are now shifting their menu offerings to support those customers. Here, Vogue ...

Novo Nordisk (CPSE:NOVO B) has entered a partnership with Hims & Hers to provide access to its FDA approved GLP-1 obesity and diabetes drugs, Ozempic and Wegovy, through telehealth channels. The ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies, betting on capacity gaps, pricing advantage and ...

GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity. But as they become more available, some people might choose to use them even if they're not currently overweight. NPR's ...

A new study finds quitting GLP-1 drugs like Ozempic can reverse health gains and increase heart health risks. Patients who stopped taking the medication saw a higher risk for heart attack, stroke, or ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose. There is new evidence that drugs like Ozempic can reduce ...